Pharmacological Perspectives of Ayurvedic herbs viz. Alstonia scholaris L., Picrorhiza kurroa, Swertia chirata and Caesalpinia crista against COVID- 19: A Mini-Review

(E-pub Ahead of Print)

Author(s): Vijay Kumar*, Shyam Babu Singh, Simranjeet Singh

Journal Name: Mini-Reviews in Organic Chemistry


Become EABM
Become Reviewer
Call for Editor

Abstract:

Pandemic, COVID-19 came in existence in late December 2019 at Wuhan, China. To cure the COVID-19 and re-duction in morbidity, development of potential vaccines and antiviral drugs may take months or years. To reduce the pres-sure on healthcare infrastructure, traditional medicines may use as an alternative measure. The rationale of current study was to provide the pharmacological details of Ayurvedic herbs viz. Alstonia scholaris L., Picrorhiza kurroa, Swertia chirata and Caesalpinia crista w.r.t. symptoms of COVID-19. The available information on the ethno-medicinal uses, phytochemistry, and pharmacology was collected via a library and electronic searches in Sci-Finder, Pub-Med, Science Direct, Google Scholar for the period up to 31 August 2020. The major symptoms of COVID-19 include pro-inflammation, inhibition of Angiotensin Converting Enzyme II (ACE2) and reactive oxygen species. Literature search revealed that all herbs under study are potent against two or more symptoms of COVID-19. All four Ayurvedic herbs viz. Alstonia scholaris L., Picrorhi-za kurroa, Swertia chirata and Caesalpinia crista may be a good option including other traditional drugs during the out-break of COVID-19. In-depth experimental, preclinical and clinical studies are required in future to develop a potent drug against COVID-19.

Keywords: COVID-19, pro-inflammation, inhibition of Angiotensin Converting Enzyme II (ACE2), reactive oxygen species, herbal drugs.

Rights & PermissionsPrintExport Cite as

Article Details

(E-pub Ahead of Print)
DOI: 10.2174/1570193X17999201102200944
Price: $95

Article Metrics

PDF: 52